[Form 4] Tivic Health Systems, Inc. Insider Trading Activity
Sheryle Bolton, a director of Tivic Health Systems, Inc. (TIVC), was granted a stock option on 08/06/2025 to purchase 12,500 shares of common stock at an exercise price of $3.32 per share. The option is held directly and covers 12,500 underlying shares. The option expires on 08/05/2035.
The grant vests in four equal quarterly installments (rounded down) measured from the grant date, with 100% vesting upon the first anniversary of the grant. The form was signed by an attorney-in-fact on behalf of the reporting person.
Sheryle Bolton, membro del consiglio di amministrazione di Tivic Health Systems, Inc. (TIVC), ha ricevuto il 08/06/2025 un'opzione su azioni per acquistare 12,500 azioni ordinarie al prezzo di esercizio di $3.32 per azione. L'opzione 猫 detenuta direttamente e copre 12,500 azioni sottostanti. L'opzione scade il 08/05/2035.
La concessione matura in quattro rate trimestrali uguali (arrotondate per difetto) calcolate a partire dalla data di concessione, con il 100% delle azioni che matura al primo anniversario della concessione. Il modulo 猫 stato firmato da un procuratore in rappresentanza della persona che ha presentato la comunicazione.
Sheryle Bolton, directora de Tivic Health Systems, Inc. (TIVC), recibi贸 el 08/06/2025 una opci贸n sobre acciones para comprar 12,500 acciones ordinarias a un precio de ejercicio de $3.32 por acci贸n. La opci贸n se mantiene de forma directa y cubre 12,500 acciones subyacentes. La opci贸n vence el 08/05/2035.
La concesi贸n se consolida en cuatro cuotas trimestrales iguales (redondeadas hacia abajo) contadas desde la fecha de la concesi贸n, con un 100% de adquisici贸n en el primer aniversario de la misma. El formulario fue firmado por un apoderado en nombre de la persona informante.
Sheryle Bolton鞚� Tivic Health Systems, Inc. (TIVC)鞚� 鞚挫偓搿滌劀 08/06/2025鞐� 欤检嫕毵れ垬靹犿儩甓岇潉 攵�鞐皼鞎� 氤错喌欤� 12,500欤茧ゼ 欤茧嫻 $3.32鞚� 頄夓偓臧�搿� 毵れ垬頃� 靾� 鞛堦矊 霅橃棃鞀惦媹雼�. 頃措嫻 鞓奠厴鞚� 歆侅爲 氤挫湢霅橂┌ 12,500欤检潣 旮办磮欤检嫕鞚� 雽�靸侅溂搿� 頃╇媹雼�. 鞓奠厴鞚� 毵岆鞚检潃 08/05/2035鞛呺媹雼�.
攵�鞐秳鞚� 攵�鞐澕搿滊秬韯� 瓿勳偘頃橃棳 雱� 氩堨潣 霃欖澕頃� 攵勱赴氤� 頃犽秬(雮措 觳橂Μ)搿� 氩犾姢韺呺悩氅�, 攵�鞐� 1欤茧厔鞐愲姅 100%臧� 氩犾姢韺呺惄雼堧嫟. 靹滊電� 氤搓碃鞛愲ゼ 雽�鞁犿晿鞐� 鞙勳瀯氚涭潃 雽�毽澑鞚� 靹滊獏頄堨姷雼堧嫟.
Sheryle Bolton, administratrice de Tivic Health Systems, Inc. (TIVC), s'est vue accorder le 08/06/2025 une option d'achat portant sur 12 500 actions ordinaires au prix d'exercice de 3,32 $ par action. L'option est d茅tenue directement et couvre 12 500 actions sous-jacentes. L'option expirera le 08/05/2035.
La subvention acquiert ses droits en quatre versements trimestriels 茅gaux (arrondis par d茅faut) calcul茅s 脿 partir de la date d'attribution, avec une acquisition 脿 100 % au premier anniversaire de l'attribution. Le formulaire a 茅t茅 sign茅 par un mandataire au nom de la personne d茅clarante.
Sheryle Bolton, Direktorin von Tivic Health Systems, Inc. (TIVC), erhielt am 08/06/2025 eine Aktienoption zum Kauf von 12.500 Stammaktien zum Aus眉bungspreis von $3,32 pro Aktie. Die Option wird direkt gehalten und umfasst 12.500 zugrundeliegende Aktien. Die Option l盲uft am 08/05/2035 ab.
Die Zuteilung vestet in vier gleichen viertelj盲hrlichen Tranchen (abgerundet), gerechnet ab dem Zuteilungsdatum, wobei zum ersten Jahrestag der Zuteilung 100% vesten. Das Formular wurde von einem Bevollm盲chtigten im Namen der meldenden Person unterzeichnet.
- Director Sheryle Bolton received a clear, time-based equity award: 12,500 stock options with explicit quarterly vesting and full vesting after one year
- Long-term alignment: Option expiration in 2035 provides a multi-year incentive horizon
- None.
Insights
TL;DR: Routine director equity award; grants management alignment but no evidence here of material dilution or extraordinary terms.
The filing documents a standard director equity grant: a stock option for 12,500 shares at an exercise price of $3.32, exercisable under a vesting schedule of four equal quarterly installments and fully vested after one year. The option is direct and expires on 08/05/2035. From a governance perspective, the disclosure is complete on grant mechanics and vesting. The filing does not provide information on total outstanding shares, prior holdings, or option plan limits, so materiality relative to shareholder dilution cannot be assessed from this form alone.
TL;DR: Compensation details are clear: 12,500 options at $3.32 with time-based quarter vesting and a 10-year term; appears routine.
The derivative reported is a stock option to purchase 12,500 shares with an exercise price of $3.32 and an expiration date of 08/05/2035. The vesting triggers are time-based: four equal quarterly installments culminating in full vesting at one year. The form confirms direct ownership of the option post-grant. Absent additional pay-rate, grant-date valuation, or company-wide compensation context, this grant reads as a typical long-term incentive for a director rather than an extraordinary compensation event.
Sheryle Bolton, membro del consiglio di amministrazione di Tivic Health Systems, Inc. (TIVC), ha ricevuto il 08/06/2025 un'opzione su azioni per acquistare 12,500 azioni ordinarie al prezzo di esercizio di $3.32 per azione. L'opzione 猫 detenuta direttamente e copre 12,500 azioni sottostanti. L'opzione scade il 08/05/2035.
La concessione matura in quattro rate trimestrali uguali (arrotondate per difetto) calcolate a partire dalla data di concessione, con il 100% delle azioni che matura al primo anniversario della concessione. Il modulo 猫 stato firmato da un procuratore in rappresentanza della persona che ha presentato la comunicazione.
Sheryle Bolton, directora de Tivic Health Systems, Inc. (TIVC), recibi贸 el 08/06/2025 una opci贸n sobre acciones para comprar 12,500 acciones ordinarias a un precio de ejercicio de $3.32 por acci贸n. La opci贸n se mantiene de forma directa y cubre 12,500 acciones subyacentes. La opci贸n vence el 08/05/2035.
La concesi贸n se consolida en cuatro cuotas trimestrales iguales (redondeadas hacia abajo) contadas desde la fecha de la concesi贸n, con un 100% de adquisici贸n en el primer aniversario de la misma. El formulario fue firmado por un apoderado en nombre de la persona informante.
Sheryle Bolton鞚� Tivic Health Systems, Inc. (TIVC)鞚� 鞚挫偓搿滌劀 08/06/2025鞐� 欤检嫕毵れ垬靹犿儩甓岇潉 攵�鞐皼鞎� 氤错喌欤� 12,500欤茧ゼ 欤茧嫻 $3.32鞚� 頄夓偓臧�搿� 毵れ垬頃� 靾� 鞛堦矊 霅橃棃鞀惦媹雼�. 頃措嫻 鞓奠厴鞚� 歆侅爲 氤挫湢霅橂┌ 12,500欤检潣 旮办磮欤检嫕鞚� 雽�靸侅溂搿� 頃╇媹雼�. 鞓奠厴鞚� 毵岆鞚检潃 08/05/2035鞛呺媹雼�.
攵�鞐秳鞚� 攵�鞐澕搿滊秬韯� 瓿勳偘頃橃棳 雱� 氩堨潣 霃欖澕頃� 攵勱赴氤� 頃犽秬(雮措 觳橂Μ)搿� 氩犾姢韺呺悩氅�, 攵�鞐� 1欤茧厔鞐愲姅 100%臧� 氩犾姢韺呺惄雼堧嫟. 靹滊電� 氤搓碃鞛愲ゼ 雽�鞁犿晿鞐� 鞙勳瀯氚涭潃 雽�毽澑鞚� 靹滊獏頄堨姷雼堧嫟.
Sheryle Bolton, administratrice de Tivic Health Systems, Inc. (TIVC), s'est vue accorder le 08/06/2025 une option d'achat portant sur 12 500 actions ordinaires au prix d'exercice de 3,32 $ par action. L'option est d茅tenue directement et couvre 12 500 actions sous-jacentes. L'option expirera le 08/05/2035.
La subvention acquiert ses droits en quatre versements trimestriels 茅gaux (arrondis par d茅faut) calcul茅s 脿 partir de la date d'attribution, avec une acquisition 脿 100 % au premier anniversaire de l'attribution. Le formulaire a 茅t茅 sign茅 par un mandataire au nom de la personne d茅clarante.
Sheryle Bolton, Direktorin von Tivic Health Systems, Inc. (TIVC), erhielt am 08/06/2025 eine Aktienoption zum Kauf von 12.500 Stammaktien zum Aus眉bungspreis von $3,32 pro Aktie. Die Option wird direkt gehalten und umfasst 12.500 zugrundeliegende Aktien. Die Option l盲uft am 08/05/2035 ab.
Die Zuteilung vestet in vier gleichen viertelj盲hrlichen Tranchen (abgerundet), gerechnet ab dem Zuteilungsdatum, wobei zum ersten Jahrestag der Zuteilung 100% vesten. Das Formular wurde von einem Bevollm盲chtigten im Namen der meldenden Person unterzeichnet.
FAQ
What did the Form 4 for TIVC disclose about Sheryle Bolton's transaction?
What is the vesting schedule for the TIVC option granted to Sheryle Bolton?
When does the option granted to the TIVC director expire?
Is the option held directly or indirectly for the TIVC reporting person?
What is the exercise price of the derivative security in the TIVC Form 4?
Does the Form 4 indicate how many derivative securities are owned after the transaction?
